Clinical Trials Browser

Phase 3 × Interventional × Non Small Cell Lung Carcinoma NSCLC × Clear all

NCT03003962 2026-03-11

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

Phase 3 Active not recruiting

669 enrolled 54 charts

Non Small Cell Lung Carcinoma NSCLC